Trade Summary

3 days ago, Matsuda Masaru, serving as See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 8,256 shares at $23.31 per share, for a total transaction value of $192,415.00. Following this transaction, Matsuda Masaru now holds 126,689 shares of ARQT.

This sale represents a 6.00% decrease in Matsuda Masaru's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 4, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 6, 2026, 2 days after the trade was made.

Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.